➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
McKesson
Moodys
Dow
McKinsey

Last Updated: July 27, 2021

DrugPatentWatch Database Preview

CARAFATE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Carafate, and what generic alternatives are available?

Carafate is a drug marketed by Allergan and is included in two NDAs.

The generic ingredient in CARAFATE is sucralfate. There are fourteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the sucralfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Carafate

A generic version of CARAFATE was approved as sucralfate by TEVA on March 29th, 1996.

  Try it Free

US Patents and Regulatory Information for CARAFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan CARAFATE sucralfate SUSPENSION;ORAL 019183-001 Dec 16, 1993 AB RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Allergan CARAFATE sucralfate TABLET;ORAL 018333-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
McKesson
Moodys
Dow
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.